Role of exosomal miRNA-19a/19b and PTEN in brain tumor diagnosis

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Tan Y, Luo X, Lv W et al. Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis. Cell Death Dis. 12(6), 547 (2021).
  Medline CASGoogle Scholar
• 2. Mansoori B, Baradaran B, Nazari A, Gaballu FA, Cho WCS, Mansoori B. MicroRNAs in the cancer cell-to-cell communication: an insight into biological vehicles. Biomed. Pharmacother. 153, 113449 (2022).
  Medline CASGoogle Scholar
• 3. Garofalo M, Croce CM. MicroRNAs: master regulators as potential therapeutics in cancer. Annu. Rev. Pharmacol. 51, 25–43 (2011).
  CASGoogle Scholar
• 4. Silvestro S, Mazzon E. MiRNAs as promising translational strategies for neuronal repair and regeneration in spinal cord injury. Cells 11(14), 2177 (2022).
  Medline CASGoogle Scholar
• 5. Peng Y, Croce CM. The role of microRNAs in human cancer. Signal Transduct. Target. Ther. 1(1), 1–9 (2016).
  Google Scholar
• 6. Bhome R, Del Vecchio F, Lee GH et al. Exosomal microRNAs (exomiRs): small molecules with a big role in cancer. Cancer Lett. 420, 228–235 (2018).
  Medline CASGoogle Scholar
• 7. Nalamolu KR, Venkatesh I, Mohandass A et al. Exosomes secreted by the cocultures of normal and oxygen–glucose-deprived stem cells improve post-stroke outcome. Neuromolecular Med. 21, 529–539 (2019).
  Medline CASGoogle Scholar
• 8. Jia Z, Wang K, Zhang A et al. miR-19a and miR-19b overexpression in gliomas. Pathol. Oncol. Res. 19, 847–853 (2013). •• This article evaluates the level of expression of the miR-17-92 cluster encompassing miR-19a and 19b in astrocytic glioma tissues and malignant glioma cell lines. The expression levels of both were observed to be upregulated in gliomas. This study indicates a positive association of miR-19a and19b with gliomagenesis with PTEN as a downstream target gene of the selected miRNAs.
  Medline CASGoogle Scholar
• 9. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets 8(3), 187–198 (2008).
  Medline CASGoogle Scholar
• 10. Wang W, Liu L, Tian Y. miR-19-3p targets PTEN to regulate cervical cancer cell proliferation, invasion, and autophagy. Genet. Res. https://doi.org/10.1155/2023/4784500 (2023). • This article suggests that miR-19b-3p functions by targeting PTEN in regulating invasion, proliferation and autophagy of cervical cancer cells. The results indicate the potential role of miR-19-3p as a downstream target for treating cervical cancer.
  Google Scholar
• 11. Sun J, Jia Z, Li B et al. miR-19 regulates the proliferation and invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling. Oncotarget 8(67), 110785 (2017).
  MedlineGoogle Scholar
• 12. Ardizzone A, Calabrese G, Campolo M et al. Role of miRNA-19a in cancer diagnosis and poor prognosis. Int. J. Mol. Sci. 22(9), 4697 (2021).
  Medline CASGoogle Scholar
• 13. Wang W, Zhang A, Hao Y, Wang G, Jia Z. The emerging role of miR-19 in glioma. J. Cell. Mol. Med. 22(10), 4611–4616 (2018). •• This article proposes that miR-19 is a potential novel target in treating glioma. It might regulate the radiotherapy and chemotherapeutic effect by adjusting the sensitivity of glioma cells, which may serve as a new strategy for glioma therapy.
  Medline CASGoogle Scholar
• 14. Blanco-Aparicio C, Renner O, Leal JF, Carnero A. PTEN, more than the AKT pathway. Carcinogenesis 28(7), 1379–1386 (2007).
  Medline CASGoogle Scholar
• 15. Liu C, Wu H, Li Y et al. SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway. J. Neurooncol. 135, 263–272 (2017).
  Medline CASGoogle Scholar
• 16. Ruan J, Chen H, Kurgan L, Chen K, Kang C, Pu P. HuMiTar: a sequence-based method for prediction of human microRNA targets. Algorithms Mol. Biol. 3, 1–12 (2008).
  MedlineGoogle Scholar
• 17. Jia Z, Wang K, Zhang A et al. miR-19a and miR-19b overexpression in gliomas. Pathol. Oncol. Res. 19, 847–853 (2013).
  Medline CASGoogle Scholar
• 18. Dobson RC, Patel TR. Analytical ultracentrifugation: still the gold standard that offers multiple solutions. Eur. Biophys. J. 49, 673–676 (2020).
  MedlineGoogle Scholar
• 19. Wu Y, Deng W, Klinke DJ II. Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst 140(19), 6631–6642 (2015).
  Medline CASGoogle Scholar
• 20. Shao H, Chung J, Balaj L et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat. Med. 18(12), 1835–1840 (2012).
  Medline CASGoogle Scholar
• 21. Mian SY, Nambiar A, Kaliaperumal C. Phytotherapy for the treatment of glioblastoma: a review. Front. Surg. 9, 844993 (2022).
  MedlineGoogle Scholar
• 22. Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-Oncology 20(Suppl. 4), iv1–iv86 (2018).
  MedlineGoogle Scholar
• 23. Wrensch M, Lee M, Miike R, Newman B, Bargar G, Davis R. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am. J. Epidemiol. 145(7), 581–593 (1997).
  Medline CASGoogle Scholar
• 24. Ostrom QT, Adel Fahmideh M, Cote DJ et al. Risk factors for childhood and adult primary brain tumors. Neuro-Oncology 21(11), 1357–1375 (2019).
  Medline CASGoogle Scholar
• 25. Peter ID, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol. Rev. 17(2), 382–414 (1995).
  MedlineGoogle Scholar
• 26. Kim SJH, Ioannides SJ, Elwood JM. Trends in incidence of primary brain cancer in New Zealand, 1995 to 2010. Aust. N. Z. J. Public Health 39(2), 148–152 (2015).
  MedlineGoogle Scholar
• 27. Malmir H, Shayanfar M, Mohammad-Shirazi M, Tabibi H, Sharifi G, Esmaillzadeh A. Tea and coffee consumption in relation to glioma: a case–control study. Eur. J. Nutr. 58, 103–111 (2019).
  MedlineGoogle Scholar
• 28. Ogawa T, Sawada N, Iwasaki M et al. Coffee and green tea consumption in relation to brain tumor risk in a Japanese population. Int. J. Cancer 139(12), 2714–2721 (2016).
  Medline CASGoogle Scholar
• 29. Harding CV, Heuser JE, Stahl PD. Exosomes: looking back three decades and into the future. J Cell Biol 200(4), 367 (2013).
  Medline CASGoogle Scholar
• 30. Karami Fath M, Azami J, Masoudi A, Mosaddeghi Heris R, Rahmani E, Alavi F. Exosome-based strategies for diagnosis and therapy of glioma cancer. Cancer Cell. Int. 22(1), 262 (2022). • This review demonstrates that tumor-derived exosomes may serve as a diagnostic and prognostic therapeutic strategy and biomarker against immune cells for targeting invasive tumor cells, including glioblastomas.
  MedlineGoogle Scholar
• 31. Wang J, Zheng Y, Zhao M. Exosome-based cancer therapy: implication for targeting cancer stem cells. Front. Pharmacol. 7, 533 (2017).
  Medline CASGoogle Scholar
• 32. Olive V, Bennett MJ, Walker JC et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23(24), 2839–2849 (2009). •• This research article indicats miR-19 as a potential oncogenic component of the miR-17-92 cluster, necessary for promoting C-MYC-induced lymphomagenesis while repressing apoptosis. The oncogenic activity of miR-19 is associated with repression of PTEN, a tumor suppressor gene.
  Medline CASGoogle Scholar
• 33. Zhi F, Shao N, Wang R et al. Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro-Oncology 17(3), 383–391 (2015). • This study concludes that serum miRNAs may serve as potentially noninvasive biomarkers for the prognosis and diagnosis of astrocytomas.
  Medline CASGoogle Scholar
• 34. Liu HN, Wu H, Tseng YJ et al. Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer. BMC Cancer 18(1), 1–11 (2018).
  MedlineGoogle Scholar
• 35. Sierzega M, Kaczor M, Kolodziejczyk P, Kulig J, Sanak M, Richter P. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331. Br. J. Cancer 117(2), 266–273 (2017).
  Medline CASGoogle Scholar
• 36. Wang F, Li T, Zhang B et al. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem. Biophys. Res. Commun. 434(3), 688–694 (2013).
  Medline CASGoogle Scholar
• 37. Wu TY, Zhang TH, Qu LM et al. miR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. Int. J. Clin. Exp. Pathol. 7(1), 56 (2014).
  MedlineGoogle Scholar
• 38. Tantawy M, Elzayat MG, Yehia D, Taha H. Identification of microRNA signature in different pediatric brain tumors. Genet. Mol. Biol. 41, 27–34 (2018).
  Medline CASGoogle Scholar
• 39. Petrocca F, Visone R, Onelli MR et al. E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13(3), 272–286 (2008).
  Medline CASGoogle Scholar
• 40. Weng LP, Brown JL, Eng C. PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum. Mol. Genet. 10(6), 599–604 (2001).
  Medline CASGoogle Scholar
• 41. Qin N, Tong GF, Sun LW, Xu XL. Long noncoding RNA MEG3 suppresses glioma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of miR-19a. Oncol. Res. Pre-Clin. Clin. Cancer Ther. 25(9), 1471–1478 (2017).
  Google Scholar
• 42. Patnam S, Samal R, Koyyada R et al. Exosomal PTEN as a predictive marker of aggressive gliomas. Neurol. India 70(1), 215 (2022).
  MedlineGoogle Scholar
• 43. Jiang TY, Shi YY, Cui XW et al. PTEN deficiency facilitates exosome secretion and metastasis in cholangiocarcinoma by impairing TFEB-mediated lysosome biogenesis. Gastroenterology 164(3), 424–438 (2023).
  Medline CASGoogle Scholar
• 44. Gabriel K, Ingram A, Austin RF et al. Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer. PLOS ONE 8(7), e70047 (2013).
  Medline CASGoogle Scholar
• 45. Koul D. PTEN signaling pathways in glioblastoma. Cancer Biol.Ther. 7(9), 1321–1325 (2008). •• This research illustrates genetic aberrations including methylation and mutation in PTEN have been identified in at least 60% of glioblastoma. It demonstrates the importance of PTEN in the progression of glioma, evaluating the efficacy of targeting PTEN in glioblastoma.
  Medline CASGoogle Scholar
• 46. Silvestro S, Mazzon E. MiRNAs as promising translational strategies for neuronal repair and regeneration in spinal cord injury. Cells 11(14), 2177 (2022).
  Medline CASGoogle Scholar
• 47. Ding C, Qian C, Hou S et al. Exosomal miRNA-320a is released from hAMSCs and regulates SIRT4 to prevent reactive oxygen species generation in POI. Mol. Ther. Nucleic Acids 21, 37–50 (2020).
  Medline CASGoogle Scholar